Opio Receives $1.5M Award from National Institutes of Health
The Opio team is excited to announce that we have received a $1.5 million award from the National Institute of Drug Abuse (NIDA), a division of the National Institutes of Health (NIH).
First-Ever Robotic Methadone Dose Assembly System Undergoes Beta Testing
Opio's groundbreaking robotic methadone dose assembly system is currently undergoing closed beta testing with CompDrug, a nonprofit Opioid Treatment Program (OTP) in Ohio
Opio Receives Fast Track Funding from NIH to Expand Revolutionary Opioid Treatment Program to Underserved Areas
Opio, a groundbreaking healthcare technology company, announced today that the National Institutes of Health (NIH) has awarded the company Fast Track funding for their innovative opioid treatment program
Columbus' CompDrug Opioid Treatment Program beta tests robot to fill methadone doses
Columbus' CompDrug Opioid Treatment Program is the first to beta test a robot from Opio called Zing that helps fill methadone doses as nurses interact with patients.
